Nyxoah

medical devices

About

Nyxoah is a medical technology company based in Mont-Saint-Guibert, Belgium, focused on developing solutions for Obstructive Sleep Apnea (OSA). Founded in 2009, Nyxoah has expanded globally, with offices in Belgium, Israel, Australia, and the United States, employing around 135 people. The company's flagship product, the Genio® system, is a hypoglossal nerve stimulation therapy that offers a minimally invasive alternative to traditional OSA treatments like CPAP devices. The Genio® system received CE Mark approval in 2019 and achieved FDA PMA approval in August 2025, allowing for its commercialization in the U.S. market. Nyxoah serves patients with moderate to severe OSA and healthcare providers seeking advanced treatment options. The company emphasizes clinical validation and regulatory compliance to enhance patient outcomes worldwide.

Technologies

Mailchimp Mandrill Rackspace MailGun Outlook Amazon AWS Apache Google Analytics Ubuntu Google Tag Manager Mobile Friendly Bootstrap Framework reCAPTCHA Remote

Keywords

neurostimulation & obstructive sleep apnea medical/dental instruments health care medical equipment manufacturing minimally invasive implantation healthcare equipment & supplies therapy support services clinical research medical device commercialization sleep disorder treatment sleep disorder innovation label expansion medical devices patient support minimally invasive therapy medical equipment and supplies manufacturing hypoglossal nerve stimulation therapy clinical development patient compliance ansa cervicalis stimulation medical technology market expansion dream study b2b neurostimulation patient-centered approach genio system obstructive sleep apnea medical technology innovation market readiness

Location

12 Rue Edouard Belin, Mont-Saint-Guibert, Walloon Region, Belgium, 1435

Related Companies

Companies in the same industry